Form 4: Fennec Pharmaceuticals Executive Sells Shares
Insider Transaction (Form 4)
Pierre Sargis Sayad, Chief Medical Officer of Fennec Pharmaceuticals Inc., sold 12,000 shares of common stock on August 31, 2026 for $12.18 per share.
Summary
- Grant/award: acquired 168 Common Shares on August 31, 2026; holds 21,519 after (Direct).
- Open-market sale: disposed of 12,000 Common Shares at $12.18 ($146,160) on August 31, 2026; holds 9,519 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $146,160 of stock on the open market.
Insider Transactions
Pierre Sargis Sayad — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Grant/award | Common Shares | 168 | — | — | 21,519 |
| 2026-08-31 | Open-market sale | Common Shares | 12,000 | $12 | $146.2K | 9,519 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Grant/award (168 shares) |
| 2026-08-31 | Open-market sale (12,000 shares) |
Keywords
insider transaction, Form 4, FENC, FENNEC PHARMACEUTICALS INC., bearish, Pierre Sargis Sayad
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.